
Conceptus (NSDQ:CPTS) agreed to a buyout by Bayer (PINK:BAYRY) in a deal valued at $1.1 billion.
The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Conceptus (NSDQ:CPTS) touted a Q3 return to the black, back from previous losses reporting for the same period last year.
The Mountain View medical device maker posted $2.3 million net income, or 7¢ per share, on sales of $35.5 million. That compared with net loss of $2.9 million, or 9¢ per share, during the same period last year.
Billionaire hedge fund manager David Tepper, of Appaloosa Management, bought 7.8 million shares of Boston Scientific stock during the 4th quarter, according to regulatory filings, for a stake with a market value of $41.6 million as of Dec. 31.